Doliver Advisors LP Sells 333 Shares of The Procter & Gamble Company (NYSE:PG)

Doliver Advisors LP lessened its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 4.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,866 shares of the company’s stock after selling 333 shares during the period. Doliver Advisors LP’s holdings in Procter & Gamble were worth $1,319,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in PG. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $29,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble in the 3rd quarter worth $33,000. Quest Partners LLC bought a new position in Procter & Gamble in the 2nd quarter worth $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in Procter & Gamble during the second quarter valued at $44,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

PG stock traded down $4.18 during trading on Monday, hitting $160.95. 4,264,220 shares of the company’s stock traded hands, compared to its average volume of 4,916,294. The business has a fifty day simple moving average of $170.21 and a 200 day simple moving average of $169.85. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market capitalization of $379.04 billion, a price-to-earnings ratio of 27.75, a P/E/G ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s revenue was down .6% on a year-over-year basis. During the same quarter last year, the business posted $1.83 earnings per share. As a group, research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.50%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is 69.31%.

Analyst Ratings Changes

Several research firms have recently commented on PG. Evercore ISI raised their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. DA Davidson reaffirmed a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a report on Friday, December 27th. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, Morgan Stanley upped their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $180.45.

Check Out Our Latest Stock Report on Procter & Gamble

Insider Activity

In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.